Drugs / mRNA-1644
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05414786 | May 2022 → Jun 2023 | HIV infectious disease | International AIDS Vaccine Initiative | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-1644 | “A Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644)” NCT05414786 ↗ |
| Modality | Messenger RNA (mRNA) | “eOD-GT8 60mer mRNA Vaccine (mRNA-1644)” NCT05414786 ↗ |